Molecular Biological Studies on Processing of Amyloid Precursor Protein in Lysosomal Pathway

淀粉样前体蛋白在溶酶体途径中加工的分子生物学研究

基本信息

  • 批准号:
    05670817
  • 负责人:
  • 金额:
    $ 1.28万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1994
  • 项目状态:
    已结题

项目摘要

Proteolytic proccessing of amyloid precursor protein (APP) to generate amyloid beta protein (Abeta) in lysosomal pathway, and an effect of chloroquine, a potent lysosomotropic agent, on the processing were studied using variety of cultured cells.1.Antibodies raised against specific protein to intracellular compartments under lysosomal pathway : Lysosomal pathway consists of endosome, primary, secondary lysosomes, and transport vesicles. There are specific proteins to these intracellular compartments, transferrin receptor for endosome, rab 7 for primary lysosome, and cathepsin D for secondary lysosome. Antibodies against synthetic peptides homologous to amino acid sequence of these proteins were successfully established.2.Proteolytic processing of APP to A beta in cultured human cells under Chloroquine treatment : HUT78, derived from human T cell, U937, derived from human monocyte, and HeLa cell were cultured.1) Proteolytic processing of APP to A beta in cultured human cells without Chl … More oroquine treatment(1) Immunohistochemical studies : Antibodies against intracellular compartment specific protein stained unique intracellular structures respectively. Transferrin receptor antibody labeled relatively large vesicles, and rab 7 antibody immunostained numerous small vesicles. Cathepsin D antibody labeled intracellular granular materials. APP and Abeta (Abeta17-28) antibodies demonstrated cell surface dot-like structures and cytoplasmic fine granular materials.(2) Biochemical studies of APP processing : Many amyloidogenic and non-amyloidogenic APP fragments were detectable in cell fractionate. Western blot analyzes showed that 4 kDa Abeta fragment, was observed in mitochondrial and cytosolic fractions.2) Proteolytic processing of APP to Abeta in cultured human cells under Chloroquine treatment : Chloroquine induced vacuoles in cytoplasm of the cultured cells after 12 hours. Vacuoles increased in number until up to 24 hours.(1) Immunohistochemical studies : A number of these vacuoles were stained with transferrin receptor antibody, rab 7 antibody, and were also labeled with both APP and Abeta antibodies.(2) Biochemical studies of APP processing : 4 kDa Abeta fragment became visualized more intensely after chloroquine treatment in mitochondrial and cytosolic fractions.Our data provides further evidence for participation of acidic compartments, for example, lysosomal pathway, in the generation of amyloidogenic processing proteolytic cleaved APP products and Abeta. Less
本实验研究了淀粉样前体蛋白(APP)在溶酶体途径中水解生成淀粉样β蛋白(Abeta)的过程,以及氯喹对该过程的影响。1.溶酶体途径:溶酶体途径由内体、初级溶酶体、次级溶酶体和转运囊泡组成。这些细胞内区室有特定的蛋白质,内体有转铁蛋白受体,初级溶酶体有rab 7,次级溶酶体有组织蛋白酶D。2.氯喹处理下人细胞APP蛋白水解为A β的过程:培养人T细胞HUT 78、人单核细胞U937和HeLa细胞; 1)不加Chl处理的人细胞APP蛋白水解为A β; 2)细胞培养液中加入Chl处理的人细胞APP蛋白水解为A β; 3)细胞培养液中加入Chl处理的人细胞APP蛋白水解为A β ...更多信息 (1)免疫组化研究:抗细胞内区室特异性蛋白抗体分别染色独特的细胞内结构。转铁蛋白受体抗体标记相对较大的囊泡,rab 7抗体免疫染色许多小囊泡。组织蛋白酶D抗体标记的细胞内颗粒物质。APP和Abeta(Abeta 17 -28)抗体显示细胞表面点状结构和细胞质细颗粒物质。(2)APP加工的生化研究:在细胞碎片中可检测到许多淀粉样蛋白和非淀粉样蛋白APP片段。Western blot分析显示,在线粒体和胞浆中均观察到4kDa的A β片段。2)氯喹处理培养的人细胞中APP蛋白水解为A β:氯喹处理12 h后,培养的细胞质中出现空泡。直至24小时,微球数量增加。(1)免疫组织化学研究:用转铁蛋白受体抗体、rab 7抗体对这些空泡中的一些进行染色,并且还用APP和Abeta抗体进行标记。(2)APP加工的生化研究:氯喹处理后,线粒体和胞浆中的4 kDa Abeta片段变得更强烈,我们的数据进一步证明了酸性区室,例如溶酶体途径,参与了淀粉样蛋白形成过程中蛋白水解裂解的APP产物和Abeta的产生。少

项目成果

期刊论文数量(82)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tsuzuki K et al: "Co-localization of amyloid associated proteins with amyloid beta in rat soleus muscle in chloroquine-induced myopathy : a possible model for amyloid beta formation in Alzheimer's disease." Brain Research. 699. 260-265 (1995)
Tsuzuki K 等人:“在氯喹诱导的肌病中,淀粉样蛋白相关蛋白与淀粉样蛋白 β 在大鼠比目鱼肌中的共定位:阿尔茨海默病中淀粉样蛋白 β 形成的可能模型。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tsuzuki K et al: "Potentially amyloidogenic fragment of 50 kDa and intracellvlar processing of amyloid precursor protein in cell under leupeptin" Brain Research. 659. 213-220 (1994)
Tsuzuki K 等人:“50 kDa 的潜在淀粉样蛋白生成片段和亮肽素作用下细胞中淀粉样前体蛋白的细胞内加工”大脑研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
R Fukatsu et al: "Membranous lipodystrophy(Nasu-Hakola disease)with Alzheimer's senile change" Advances in the biosciences. vol87. 33-34 (1993)
R Fukatsu 等人:“膜性脂肪营养不良(Nasu-Hakola 病)与阿尔茨海默病的老年变化”生物科学进展。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tsuzuki K et al: "Amyloidogenic fragment of amyloid precursor protein in cell cultured under leupeptin." In Israel H,Abraham F,and Yoshida M,Alzheimer's and Parkinson's Disease : Recent Developments. 119-125 (1995)
Tsuzuki K 等人:“在亮抑酶肽下培养的细胞中淀粉样前体蛋白的淀粉样蛋白生成片段。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hayashi Y et al: "Evidence for presenilin-1 involvement in amyloid angiopathy in the Alzheimer's disease-affected brain." Brain Research. (in press). (1998)
Hayashi Y 等人:“早老素 1 参与阿尔茨海默病大脑中淀粉样血管病的证据。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKAHATA Naohiko其他文献

TAKAHATA Naohiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKAHATA Naohiko', 18)}}的其他基金

An Attempt to Identify Amyloid Precursor Protein Processing Pathway Involving Lysosomal System by Vesicle Specific Protein
通过囊泡特异性蛋白鉴定涉及溶酶体系统的淀粉样前体蛋白加工途径的尝试
  • 批准号:
    07671080
  • 财政年份:
    1995
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MOLECULAR BIOLOGICAL STUDIES OF APP PROCESSING
APP 处理的分子生物学研究
  • 批准号:
    03670568
  • 财政年份:
    1991
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Development of prevention of Alzheimer's disease using transgenic soybean expressing amyloid beta protein
使用表达β淀粉样蛋白的转基因大豆预防阿尔茨海默病的进展
  • 批准号:
    19K07989
  • 财政年份:
    2019
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Collaborative Research: Dynamics of surfactant - amyloid-beta protein interactions during self-assembly
合作研究:自组装过程中表面活性剂 - 淀粉样蛋白 - β 蛋白相互作用的动力学
  • 批准号:
    1802641
  • 财政年份:
    2018
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Standard Grant
Collaborative Research: Dynamics of surfactant - amyloid-beta protein interactions during self-assembly
合作研究:自组装过程中表面活性剂 - 淀粉样蛋白 - β 蛋白相互作用的动力学
  • 批准号:
    1802588
  • 财政年份:
    2018
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Standard Grant
Collaborative Research: Dynamics of surfactant - amyloid beta protein interactions during self-assembly
合作研究:自组装过程中表面活性剂-淀粉样β蛋白相互作用的动力学
  • 批准号:
    1802793
  • 财政年份:
    2018
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Standard Grant
Analysis of a new mechanism to specifically inhibit amyloid-beta protein production
特异性抑制β-淀粉样蛋白产生的新机制分析
  • 批准号:
    18K14883
  • 财政年份:
    2018
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Aggregation of amyloid-beta protein on size-controlled lipid nanoparticles
淀粉样β蛋白在尺寸控制的脂质纳米颗粒上的聚集
  • 批准号:
    16K18860
  • 财政年份:
    2016
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Structure and molecular interactions in aggregation of amyloid beta protein
β淀粉样蛋白聚集的结构和分子相互作用
  • 批准号:
    26860020
  • 财政年份:
    2014
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
A novel therapeutic strategy for Alzheimer's disease based on the promotion of clearance mechanism of amyloid beta protein
基于促进β淀粉样蛋白清除机制的阿尔茨海默病新治疗策略
  • 批准号:
    26670126
  • 财政年份:
    2014
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Amyloid Beta-Protein: Wild Type and Familial Mutant Assembly and Inhibition
β-淀粉样蛋白:野生型和家族突变体的组装和抑制
  • 批准号:
    8728102
  • 财政年份:
    2013
  • 资助金额:
    $ 1.28万
  • 项目类别:
Amyloid Beta-Protein: Wild Type and Familial Mutant Assembly and Inhibition
β-淀粉样蛋白:野生型和家族突变体的组装和抑制
  • 批准号:
    9110110
  • 财政年份:
    2013
  • 资助金额:
    $ 1.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了